Every breakthrough needs a key

ClavystBio is a life sciences venture capital firm committed to investing in companies with global health impact

View our approach

Building Future Leaders

Our companies are developing innovative medicines and medical solutions that advance people’s health globally.

View our companies

We bring life sciences experience and international networks

Catch up on our latest news

View press releases

Companies
Singapore Venture Creation Group 65LAB Awards US$1.69 million to A*STAR-led Project Targeting the Cause of Vision Loss in Glaucoma and NAION
14 Oct 2026
Companies
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
8 Oct 2026
Companies
Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical
5 Oct 2026
Companies
Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers
30 Sept 2026

The next breakthrough starts here

Connect with us